So far, there is no "magic bullet" to cure HIV for good, but scientists are making rapid progress.
For more than a decade, doctors and researchers have announced that a handful of people around the world have been cured of ...
Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game ...
Lithium, a widely used treatment for bipolar disorder and other mood disorders, has shown early promise in suppressing HIV, McGill University researchers report.
Switching to a 2-drug ART regimen was highly effective and well tolerated in virologically suppressed patients with HIV.
Since the HIV epidemic began, the diagnosis of HIV has evolved from a death sentence to a chronic, but manageable condition by starting and staying on treatment. HIV treatment can help people live ...
The Centers for Medicare and Medicaid Services said Tuesday it seeks to lower Medicare costs for 16 medications by negotiating with their manufacturers. Among them is Biktarvy, a drug taken after HIV ...
– Investigational Long-Acting, Twice-Yearly Treatment Regimen of Lenacapavir and Broadly Neutralizing Antibodies (bNAbs) Meets Primary Endpoint in Phase 2 Study and Gains Breakthrough Therapy ...
A Q&A With Shauna Applin, ARNP. AJMC: Despite substantial therapeutic advances since the 1980s, the US is not on pace to achieve the goals of the Ending the HIV Epidemic (EHE) public health initiative ...
The National Alliance of State and Territorial AIDS Directors estimates 16,000 will lose assistance for the drugs or premiums.
The tool can be used to find providers that offer HIV testing and medications that prevent the virus, which causes AIDS.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results